journal article·2018-11-05Open access

Development of novel biotinylated chitosan-decorated docetaxel-loaded nanocochleates for breast cancer targeting

Ishwor Poudel, Raj Ahiwale, Atmaram Pawar, Kakasaheb Mahadik, C. Bothiraja

Abstract

The motive of study was to develop biotinylated chitosan (BI-CHI) decorated docetaxel (DTX) loaded nanocochleates (BI-CHI-DTX-NC) to achieve controlled drug release, improve bioavailability, targeted delivery and enhanced anticancer potency with the reduced systemic toxicity of DTX. The development involved the loading of DTX to nanocochleates (DTX-NC) through conversion of dimyristoylphosphatidylglycerol-sodium (DMPG-Na) and cholesterol bearing liposome on addition of calcium ions, followed by encapsulated DTX-NC with BI-CHI (BI-CHI-DTX- NC) and compared with DTX and DTX-NC. The release of DTX indicated strong pH dependence and implies strong hydrogen-bonding between nanocochleates and DTX. Formulated BI-CHI-DTX-NC demonstrated higher in-vitro anticancer activity in biotin over expressed human breast cancer MCF-7 cells. The targeting effect for the BI-CHI-DTX-NC was also demonstrated. The concentration of the drug needed for growth inhibition of 50% of cells in a designed time period (GI50) was 1.8 μg/ml for free DTX while it was decreased by 33.34% for the DTX-NC (1.2 μg/ml). Furthermore, the GI50 value of BI-CHI-DTX-NC was 0.2 μg/ml, i.e. an 88.89% decrease was observed as compared to DTX solution. Moreover, bioavailability of DTX from BI-CHI-DTX-NC was increased by 10-folds with longer circulation time and slower plasma elimination with low tissue distribution as compared to DTX solution. The results indicate that the BI-CHI-DTX- NC has the potential to be applied for targeting anticancer drug delivery.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Lipid Membrane Structure and Behavior · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmaceutics, Poona College of Pharmacy, Bharati Vidyapeeth Deemed University (BVDU), Pune, India;

Department of Pharmaceutical Chemistry, Poona College of Pharmacy, Bharati Vidyapeeth Deemed University (BVDU), Pune, India

References (46)

Show source-provided references
1. 10.1053/sonc.2002.3426210.1053/sonc.2002.34262 ↗
2. 10.1016/j.jconrel.2011.06.01210.1016/j.jconrel.2011.06.012 ↗
3. 10.1016/S1773-2247(08)50049-910.1016/S1773-2247(08)50049-9 ↗
4. 10.1080/21691401.2017.139487410.1080/21691401.2017.1394874 ↗
5. 10.1002/jps.2159910.1002/jps.21599 ↗
6. 10.1016/j.jconrel.2015.05.20010.1016/j.jconrel.2015.05.200 ↗
7. 10.1080/21691401.2017.132446610.1080/21691401.2017.1324466 ↗
8. 10.1016/j.jconrel.2013.01.03510.1016/j.jconrel.2013.01.035 ↗
9. 10.1016/j.ijpharm.2012.06.01410.1016/j.ijpharm.2012.06.014 ↗
10. 10.1038/srep2689510.1038/srep26895 ↗
11. 10.1080/21691401.2017.139231410.1080/21691401.2017.1392314 ↗
12. 10.1016/j.ijpharm.2013.12.02710.1016/j.ijpharm.2013.12.027 ↗
13. 10.1080/21691401.2017.136942510.1080/21691401.2017.1369425 ↗
14. 10.1097/CAD.0b013e328011333810.1097/CAD.0b013e3280113338 ↗
15. 10.1039/C5RA08550K10.1039/C5RA08550K ↗
16. 10.1038/srep4132210.1038/srep41322 ↗
17. 10.1016/j.lwt.2016.12.00610.1016/j.lwt.2016.12.006 ↗
18. 10.1016/j.ejps.2012.09.00110.1016/j.ejps.2012.09.001 ↗
19. 10.1016/j.ejmech.2008.04.02110.1016/j.ejmech.2008.04.021 ↗
20. 10.1016/j.ejpb.2008.04.01810.1016/j.ejpb.2008.04.018 ↗
21. 10.1080/21691401.2016.120226010.1080/21691401.2016.1202260 ↗
22. 10.1002/biof.810.1002/biof.8 ↗
23. 10.2174/13894501280067565010.2174/138945012800675650 ↗
24. 10.1016/j.actbio.2008.02.00210.1016/j.actbio.2008.02.002 ↗
25. 10.1080/21691401.2017.129064810.1080/21691401.2017.1290648 ↗
26. 10.1080/21691401.2016.126057810.1080/21691401.2016.1260578 ↗
27. 10.1080/21691401.2016.124354510.1080/21691401.2016.1243545 ↗
28. 10.1016/j.eurpolymj.2016.06.01410.1016/j.eurpolymj.2016.06.014 ↗
29. 10.1016/0378-5173(93)90389-W10.1016/0378-5173(93)90389-W ↗
30. 10.1016/S0076-6879(05)91018-510.1016/S0076-6879(05)91018-5 ↗
31. 10.1016/j.biopha.2014.11.01410.1016/j.biopha.2014.11.014 ↗
32. 10.1016/j.ajps.2016.04.00110.1016/j.ajps.2016.04.001 ↗
33. 10.1080/21691401.2018.142399110.1080/21691401.2018.1423991 ↗
34. 10.1016/j.colsurfb.2015.11.03310.1016/j.colsurfb.2015.11.033 ↗
35. Pavia DL · Thomson Learn Inc · 2001 · 15 · 579
36. 10.1016/S0144-8617(97)00235-X10.1016/S0144-8617(97)00235-X ↗
37. 10.1016/j.bbamem.2006.06.01410.1016/j.bbamem.2006.06.014 ↗
38. 10.1016/j.ajps.2014.09.00410.1016/j.ajps.2014.09.004 ↗
39. 10.1016/j.bmc.2007.04.00210.1016/j.bmc.2007.04.002 ↗
40. 10.1016/j.ijpharm.2011.04.02310.1016/j.ijpharm.2011.04.023 ↗
41. 10.1016/j.bbamem.2006.03.03510.1016/j.bbamem.2006.03.035 ↗
42. 10.1039/C6RA12714B10.1039/C6RA12714B ↗
43. 10.4155/tde.13.9210.4155/tde.13.92 ↗
44. 10.1517/17425247.2013.86013110.1517/17425247.2013.860131 ↗
45. 10.1016/S0169-409X(00)00121-610.1016/S0169-409X(00)00121-6 ↗
46. 10.1016/j.jss.2008.06.04910.1016/j.jss.2008.06.049 ↗